| Literature DB >> 31382605 |
Xiao-Nian Xiao1, Fan Wang1, Yi-Ting Yuan2, Jing Liu1, Yue-Zhen Liu1, Xing Yi3.
Abstract
Dihydromyricetin (DMY) has recently attracted increased interest due to its considerable health-promoting activities but there are few reports on its antibacterial activity and mechanism. In this paper, the activity and mechanisms of DMY from Ampelopsis grossedentata leaves against food-borne bacteria are investigated. Moreover, the effects of pH, thermal-processing, and metal ions on the antibacterial activity of DMY are also evaluated. The results show that DMY exhibits ideal antibacterial activity on five types of food-borne bacteria (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Salmonella paratyphi, and Pseudomonas aeruginosa). The activities of DMY against bacteria are extremely sensitive to pH, thermal-processing, and metal ions. The morphology of the tested bacteria is changed and damaged more seriously with the exposure time of DMY. Furthermore, the results of the oxidative respiratory metabolism assay and the integrity of the cell membrane and wall tests revealed that the death of bacteria caused by DMY might be due to lysis of the cell wall, leakage of intracellular ingredients, and inhibition of the tricarboxylic acid cycle (TCA) pathway.Entities:
Keywords: antibacterial activity; dihydromyricetin; food-borne bacteria; mechanism
Year: 2019 PMID: 31382605 PMCID: PMC6695662 DOI: 10.3390/molecules24152831
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The antibacterial ability of dihydromyricetin (DMY) against different bacteria.
| Bacteria | DIZ (mm) | DMY (mg/mL) | BH (mg/mL) | |||||
|---|---|---|---|---|---|---|---|---|
| Control | 3.78 mg/mL | 7.56 mg/mL | 11.34 mg/mL | MIC | MBC | MIC | MBC | |
| Gram positive | ||||||||
|
| ND | 10.6 ± 0.5 | 15 ± 0.2 | 18 ± 0.3 | 0.625 | 2.5 | 0.625 | 2.5 |
|
| ND | 8.1 ± 0.2 | 10.3 ± 0.4 | 12.3 ± 0.3 | 1.25 | 10 | 1.25 | 10 |
| Gram negative | ||||||||
|
| ND | 9.8 ± 0.3 | 12.8 ± 0.3 | 15.5 ± 0.6 | 0.3125 | 2.5 | 0.625 | 5 |
|
| ND | 10.5 ± 0.3 | 11.2 ± 0.4 | 13.1 ± 0.5 | 0.625 | 2.5 | 1.25 | 5 |
|
| ND | 10.1 ± 0.3 | 13.2 ± 0.3 | 16.3 ± 0.4 | 0.3125 | 2.5 | 0.3125 | 2.5 |
Values represent means of three independent replicates ± standard deviation (SD); ND represents not detected. BH: berberine hydrochloride; DIZ: diameter of the inhibition zone; MBC: minimum bactericidal concentration; MIC: minimum inhibitory concentration.
Figure 1Chemical structures of DMY (A) and Berberine hydrochloride (BH) (B).
Figure 2The effects of (A) Ca2+, (B) thermal processing, and (C) pH on the activities of DMY against E. coli and S. aureus.
Figure 3Morphology of bacteria treated (uppercase letters) and untreated (lowercase letters) with DMY. (A and a): E. coli for 4 h, (B and b): E. coli for 14 h, (C and c): E. coli for 24 h, (D and d): S. aureus for 4 h, (E and e): S. aureus for 14 h, (F and f): S. aureus for 24 h.
Figure 4Alkaline phosphatase (AKP) activity of S. aureus (A) and E. coli (B) before and after DMY treatment. (C) Alanine transaminase (ALT) and (D) aspartate transaminase (AST) activity of S. aureus and E. coli before and after DMY treatment. * p < 0.05 versus the control group.
Figure 5The effects of DMY on the permeability of S. aureus (A) and E. coli (B). * p < 0.05 versus the control group. a There was a significant difference between two intervals (p < 0.05). b There was no significant difference between the two intervals (p > 0.05).
The effect of DMY on the respiratory metabolism of bacteria.
| Inhibitors |
|
| ||
|---|---|---|---|---|
| IR/% | SR/% | IR/% | SR/% | |
| DMY | 20.62 | 19.24 | ||
| Malonic acid | 28.26 | 11.47 | 24.18 | 9.62 |
| Iodoacetic acid | 7.47 | 17.16 | 8.26 | 15.47 |
| Sodium phosphate tribasic dodecahydrate | 19.18 | 24.96 | 17.26 | 19.38 |
IR represents the inhibition rate of the representative inhibitor and DMY against bacteria.; SR represents the superposition rate between DMY and the representative inhibitor.